51 – 60 of 744
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease
(
- Contribution to journal › Article
-
Mark
Installation of O-glycan sulfation capacities in human HEK293 cells for display of sulfated mucins
(
- Contribution to journal › Article
-
Mark
Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia
(
- Contribution to journal › Article
-
Mark
Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB
(
- Contribution to journal › Article
- 2021
-
Mark
A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer
(
- Contribution to journal › Article
-
Mark
A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy
(
- Contribution to journal › Article
-
Mark
Synthesis and Biological Studies of O3-Aryl Galactosides as Galectin Inhibitors
(
- Contribution to journal › Article
-
Mark
Heparin fragments induce cervical inflammation by recruiting immune cells through Toll-like receptor 4 in nonpregnant mice
(
- Contribution to journal › Article
-
Mark
Memories of Bob Sim-Genius Complementologist and Cheerful Travel Companion
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Increased serum bactericidal activity of autologous serum in C2 deficiency after vaccination against Haemophilus influenzae type b, and further support for an MBL-dependent C2 bypass mechanism
(
- Contribution to journal › Article